Explore more publications!
Idaho Healthcare Hub
Submit Press Release

Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 16, 2025

Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
September 16, 2025

Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732

Indeterminate GlobeNewswire
Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak
September 16, 2025

Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak

Indeterminate GlobeNewswire
Theratechnologies reçoit l’approbation définitive du tribunal relativement au plan d’arrangement proposé visant son acquisition par Future Pak
September 16, 2025

Theratechnologies reçoit l’approbation définitive du tribunal relativement au plan d’arrangement proposé visant son acquisition par Future Pak

Indeterminate GlobeNewswire
Kane Biotech Completes U.S. FDA 510(k) Submission for revyve® Antimicrobial Wound Cleanser
September 16, 2025

Kane Biotech Completes U.S. FDA 510(k) Submission for revyve® Antimicrobial Wound Cleanser

Indeterminate GlobeNewswire
Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting
September 16, 2025

Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting

Indeterminate GlobeNewswire
NurExone Planning to Establish First U.S. Commercial Manufacturing Facility in Indiana
September 16, 2025

NurExone Planning to Establish First U.S. Commercial Manufacturing Facility in Indiana

Indeterminate GlobeNewswire
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
September 16, 2025

Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025

Indeterminate GlobeNewswire
Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes
September 16, 2025

Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes

Indeterminate GlobeNewswire
Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types
September 16, 2025

Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types

Indeterminate GlobeNewswire
Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
September 16, 2025

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Indeterminate GlobeNewswire
Sharecare, AWS, CLEAR, and Georgia Department of Community Health to discuss bringing CMS’s health tech ecosystem vision to life at Health Connect South
September 16, 2025

Sharecare, AWS, CLEAR, and Georgia Department of Community Health to discuss bringing CMS’s health tech ecosystem vision to life at Health Connect South

Indeterminate GlobeNewswire
WellSpan York Hospital expansion project rises to new heights as final beam is placed
September 16, 2025

WellSpan York Hospital expansion project rises to new heights as final beam is placed

Indeterminate GlobeNewswire
Cirtec Medical Welcomes Chris Cleary to its Board of Directors
September 16, 2025

Cirtec Medical Welcomes Chris Cleary to its Board of Directors

Indeterminate GlobeNewswire
Vielight Unveils the First Photobiomodulation-Based Vagus Nerve Stimulation Device Following Patent Approval
September 16, 2025

Vielight Unveils the First Photobiomodulation-Based Vagus Nerve Stimulation Device Following Patent Approval

Indeterminate GlobeNewswire
New VCF II Impact Report Documents the $4.9 Million Initiative's 68% Cost Reduction While Driving Dramatic Uptake Through Community-Digital Integration
September 16, 2025

New VCF II Impact Report Documents the $4.9 Million Initiative's 68% Cost Reduction While Driving Dramatic Uptake Through Community-Digital Integration

Indeterminate GlobeNewswire
IFM Establishes First-Ever Certifying Board for The Functional Medicine Field
September 16, 2025

IFM Establishes First-Ever Certifying Board for The Functional Medicine Field

Indeterminate GlobeNewswire
Fierce Pharma Week, Produced by Questex’s Fierce Pharma, Delivered a Record-Breaking Event with 3,000 Pharmaceutical Professionals
September 16, 2025

Fierce Pharma Week, Produced by Questex’s Fierce Pharma, Delivered a Record-Breaking Event with 3,000 Pharmaceutical Professionals

Indeterminate GlobeNewswire
ZKR Orthopedics Announces First Patella LIFT™ Surgeries on the East Coast at Hospital for Special Surgery in Enrollment of FDA PELICAN Trial
September 16, 2025

ZKR Orthopedics Announces First Patella LIFT™ Surgeries on the East Coast at Hospital for Special Surgery in Enrollment of FDA PELICAN Trial

Indeterminate GlobeNewswire
Gout Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in Gout Therapeutics | DelveInsight
September 16, 2025

Gout Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in Gout Therapeutics | DelveInsight

Indeterminate GlobeNewswire
UTR Therapeutics Publishes Landmark Preclinical Data in Frontiers in Pharmacology Supporting IND Submission for First-in-Class c-MYC RNA Therapeutic
September 16, 2025

UTR Therapeutics Publishes Landmark Preclinical Data in Frontiers in Pharmacology Supporting IND Submission for First-in-Class c-MYC RNA Therapeutic

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions